Atwood Danielle N, Beenken Karen E, Loughran Allister J, Meeker Daniel G, Lantz Tamara L, Graham Justin W, Spencer Horace J, Smeltzer Mark S
Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Infect Immun. 2016 Mar 24;84(4):1214-1225. doi: 10.1128/IAI.01462-15. Print 2016 Apr.
We demonstrate that mutation of xerC, which reportedly encodes a homologue of an Escherichia coli recombinase, limits biofilm formation in the methicillin-resistant Staphylococcus aureus strain LAC and the methicillin-sensitive strain UAMS-1. This was not due to the decreased production of the polysaccharide intracellular adhesin (PIA) in either strain because the amount of PIA was increased in a UAMS-1xerC mutant and undetectable in both LAC and its isogenic xerC mutant. Mutation of xerC also resulted in the increased production of extracellular proteases and nucleases in both LAC and UAMS-1, and limiting the production of either class of enzymes increased biofilm formation in the isogenic xerC mutants. More importantly, the limited capacity to form a biofilm was correlated with increased antibiotic susceptibility in both strains in the context of an established biofilm in vivo. Mutation of xerC also attenuated virulence in a murine bacteremia model, as assessed on the basis of the bacterial loads in internal organs and overall lethality. It also resulted in the decreased accumulation of alpha toxin and the increased accumulation of protein A. These findings suggest that xerC may impact the functional status of agr. This was confirmed by demonstrating the reduced accumulation of RNAIII and AgrA in LAC and UAMS-1xerC mutants. However, this cannot account for the biofilm-deficient phenotype of xerC mutants because mutation of agr did not limit biofilm formation in either strain. These results demonstrate that xerC contributes to biofilm-associated infections and acute bacteremia and that this is likely due to agr-independent and -dependent pathways, respectively.
我们证明,据报道编码大肠杆菌重组酶同源物的xerC突变会限制耐甲氧西林金黄色葡萄球菌菌株LAC和甲氧西林敏感菌株UAMS-1中的生物膜形成。这并非由于任一菌株中多糖细胞内黏附素(PIA)产量降低,因为在UAMS-1 xerC突变体中PIA的量增加,而在LAC及其同基因xerC突变体中均未检测到PIA。xerC突变还导致LAC和UAMS-1中细胞外蛋白酶和核酸酶的产量增加,而限制这两类酶中任何一类的产量都会增加同基因xerC突变体中的生物膜形成。更重要的是,在体内已形成生物膜的情况下,两株菌形成生物膜能力受限与抗生素敏感性增加相关。xerC突变在小鼠菌血症模型中也减弱了毒力,这是根据内部器官中的细菌载量和总体致死率评估得出的。它还导致α毒素积累减少和蛋白A积累增加。这些发现表明xerC可能影响agr的功能状态。通过证明LAC和UAMS-1 xerC突变体中RNAIII和AgrA的积累减少,这一点得到了证实。然而,这无法解释xerC突变体的生物膜缺陷表型,因为agr突变并未限制任一菌株中的生物膜形成。这些结果表明,xerC分别通过不依赖agr和依赖agr的途径,导致与生物膜相关的感染和急性菌血症。